Age and sex as predictors of biochemical activity in acromegaly: Analysis of 1485 patients from the German Acromegaly Register

Clinical Endocrinology

Volumn 71, Issue 3, 2009, Pages 400-405

  Petersenn, S ^a   Buchfelder, M ^b   Gerbert, B ^c   Franz, H ^d   Quabbe, H J ^e   Schulte, H M ^f   Grussendorf, M ^g   Reincke, M ^h  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Endokrinologikum Dresden   (Germany)

^d Lohmann and Birkner Health Care Consulting GmbH   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f ENDOKRINOLOGIKUM HAMBURG   (Germany)

^g Endokrinologie und Diabetologie Im Zentrum   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GERMANY; GROUPS BY AGE; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TUMOR VOLUME;

ACROMEGALY; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHILD; FEMALE; GERMANY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 68949221166     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03547.x     Document Type: Article

References (21)

1. Yamada, S. (2001) Epidemiology of pituitary tumors. In : K. Thapar, K. Kovacs, B.W. Scheithauer R.V. Lloyd eds. Diagnosis and Management of Pituitary Tumors. Humana Press Inc., Totowa, NJ, 57 69.
2. Daly, A.F., Rixhon, M., Adam, C. et al. (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism, 91, 4769 4775.
3. Schneider, H.J., Sievers, C., Saller, B. et al. (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clinical Endocrinology, 69, 432 435.
4. Reincke, M., Petersenn, S., Buchfelder, M. et al. (2006) The German Acromegaly Registry: description of the database and initial results. Experimental and Clinical Endocrinology and Diabetes, 114, 498 505.
5. Jenkins, P.J., Bates, P., Carson, M.N. et al. (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 1239 1245.
6. Lindholm, J. (2006) Growth hormone: historical notes. Pituitary, 9, 5 10.
7. Brabant, G., von zur Muhlen, A., Wuster, C. et al. (2003) Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research, 60, 53 60.
8. Saeki, N., Iuchi, T., Isono, S. et al. (1999) MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels. Neuroradiology, 41, 765 771.
9. Laron, Z., Bidlingmaier, M. Strasburger, C.J. (2007) Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. Pediatric Endocrinology Reviews, 5 (Suppl. 1 555 569.
10. Pokrajac-Simeunovic, A. Trainer, P.J. (2004) Pitfalls in the diagnosis of acromegaly. Hormone Research, 62 (Suppl. 3 74 78.
11. Parkinson, C., Ryder, W.D. Trainer, P.J. (2001) The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. Journal of Clinical Endocrinology and Metabolism, 86, 5240 5244.
12. Colao, A., Amato, G., Pedroncelli, A.M. et al. (2002) Gender- and age-related differences in the endocrine parameters of acromegaly. Journal of Endocrinological Investigation, 25, 532 538.
13. Kauppinen-Makelin, R., Sane, T., Reunanen, A. et al. (2005) A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 4081 4086.
14. Span, J.P., Pieters, G.F., Sweep, C.G. et al. (2000) Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Journal of Clinical Endocrinology and Metabolism, 85, 1121 1125.
15. Jorgensen, J.O., Christensen, J.J., Krag, M. et al. (2004) Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Hormone Research, 62 (Suppl. 1 73 76.
16. Meinhardt, U.J. Ho, K.K. (2006) Modulation of growth hormone action by sex steroids. Clinical Endocrinology, 65, 413 422.
17. van der Lely, A.J., Harris, A.G. Lamberts, S.W. (1992) The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clinical Endocrinology, 37, 181 185.
18. Turner, H.E., Adams, C.B. Wass, J.A. (1999) Pituitary tumours in the elderly: a 20 year experience. European Journal of Endocrinology, 140, 383 389.
19. Petersenn, S., Quabbe, H.J., Reincke, M. et al. (2007) Primary surgical therapy of acromegaly - results and prognostic parameters from the German acromegaly register. 51st Annual Meeting of the German Society of Endocrinology (DGE), Vol. 115 (S1 Salzburg, Abstract.
20. Agha, A. Monson, J.P. (2007) Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clinical Endocrinology, 66, 459 465.
21. Colao, A., De Rosa, M., Pivonello, R. et al. (2002) Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. Journal of Clinical Endocrinology and Metabolism, 87, 4193 4197.